These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 17230502)

  • 1. Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer.
    Feng W; Lu Z; Luo RZ; Zhang X; Seto E; Liao WS; Yu Y
    Int J Cancer; 2007 Apr; 120(8):1664-8. PubMed ID: 17230502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer.
    Lu Z; Luo RZ; Peng H; Rosen DG; Atkinson EN; Warneke C; Huang M; Nishmoto A; Liu J; Liao WS; Yu Y; Bast RC
    Clin Cancer Res; 2006 Apr; 12(8):2404-13. PubMed ID: 16638845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of ARHI in breast and ovarian cancer cells.
    Yu Y; Fujii S; Yuan J; Luo RZ; Wang L; Bao J; Kadota M; Oshimura M; Dent SR; Issa JP; Bast RC
    Ann N Y Acad Sci; 2003 Mar; 983():268-77. PubMed ID: 12724231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI.
    Li LL; Xue AM; Li BX; Shen YW; Li YH; Luo CL; Zhang MC; Jiang JQ; Xu ZD; Xie JH; Zhao ZQ
    Breast Cancer Res; 2014 May; 16(3):R56. PubMed ID: 24886710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3 acetylation-induced promoter methylation is associated with downregulation of the ARHI tumor-suppressor gene in ovarian cancer.
    Li J; Cui G; Sun L; Wang SJ; Li YL; Meng YG; Guan Z; Fan WS; Li LA; Yang YZ; You YQ; Fu XY; Yan ZF; Huang K
    Oncol Rep; 2013 Jul; 30(1):165-70. PubMed ID: 23604529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI.
    Zuo X; Qin Y; Zhang X; Ning Q; Shao S; Luo M; Yuan N; Huang S; Zhao X
    Oncol Rep; 2014 May; 31(5):2358-64. PubMed ID: 24676336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivation of the silenced and imprinted alleles of ARHI is associated with increased histone H3 acetylation and decreased histone H3 lysine 9 methylation.
    Fujii S; Luo RZ; Yuan J; Kadota M; Oshimura M; Dent SR; Kondo Y; Issa JP; Bast RC; Yu Y
    Hum Mol Genet; 2003 Aug; 12(15):1791-800. PubMed ID: 12874100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells.
    Nishimoto A; Yu Y; Lu Z; Mao X; Ren Z; Watowich SS; Mills GB; Liao WS; Chen X; Bast RC; Luo RZ
    Cancer Res; 2005 Aug; 65(15):6701-10. PubMed ID: 16061651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of histone deacetylase inhibitors on cell apoptosis and expression of the tumor suppressor genes RUNX3 and ARHI in ovarian tumors.
    Zhang L; Liu P; Li H; Xue F
    Mol Med Rep; 2013 May; 7(5):1705-9. PubMed ID: 23504001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway.
    Bao JJ; Le XF; Wang RY; Yuan J; Wang L; Atkinson EN; LaPushin R; Andreeff M; Fang B; Yu Y; Bast RC
    Cancer Res; 2002 Dec; 62(24):7264-72. PubMed ID: 12499268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
    Zhang Y; Dufau ML
    J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancers.
    Yu Y; Luo R; Lu Z; Wei Feng W; Badgwell D; Issa JP; Rosen DG; Liu J; Bast RC
    Methods Enzymol; 2006; 407():455-68. PubMed ID: 16757345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
    Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
    Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers.
    Luo RZ; Fang X; Marquez R; Liu SY; Mills GB; Liao WS; Yu Y; Bast RC
    Oncogene; 2003 May; 22(19):2897-909. PubMed ID: 12771940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells.
    Ammanamanchi S; Brattain MG
    J Biol Chem; 2004 Jul; 279(31):32620-5. PubMed ID: 15155736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EZH2-induced H3K27me3 is associated with epigenetic repression of the ARHI tumor-suppressor gene in ovarian cancer.
    Fu Y; Chen J; Pang B; Li C; Zhao J; Shen K
    Cell Biochem Biophys; 2015 Jan; 71(1):105-12. PubMed ID: 25077680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.